• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?

作者信息

Giri Jay, Nathan Ashwin

机构信息

Penn Center for Cardiovascular Outcomes, Quality & Evaluative Research, Cardiovascular Medicine Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Penn Center for Cardiovascular Outcomes, Quality & Evaluative Research, Cardiovascular Medicine Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

JACC Cardiovasc Interv. 2018 Apr 9;11(7):635-637. doi: 10.1016/j.jcin.2017.12.002. Epub 2018 Mar 14.

DOI:10.1016/j.jcin.2017.12.002
PMID:29550087
Abstract
摘要

相似文献

1
Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?对于正在接受抗凝治疗的房颤患者，经皮冠状动脉介入治疗后是否该放弃双重抗血小板治疗？
JACC Cardiovasc Interv. 2018 Apr 9;11(7):635-637. doi: 10.1016/j.jcin.2017.12.002. Epub 2018 Mar 14.
2
Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.经皮冠状动脉介入治疗的非瓣膜性心房颤动患者的当代抗栓治疗：希腊抗血小板心房颤动（GRAPE-AF）注册研究的原理和设计。
Cardiovasc Drugs Ther. 2018 Apr;32(2):191-196. doi: 10.1007/s10557-018-6789-7.
3
Triple therapy for atrial fibrillation and percutaneous coronary intervention.用于心房颤动和经皮冠状动脉介入治疗的三联疗法。
Curr Opin Cardiol. 2015 Nov;30(6):690-6. doi: 10.1097/HCO.0000000000000228.
4
Triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a viewpoint.经皮冠状动脉介入治疗的心房颤动患者的三联抗栓治疗：观点。
Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):157-162. doi: 10.1093/ehjcvp/pvx002.
5
Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy?PCI术后或急性冠状动脉综合征患者房颤的抗凝策略：三联疗法的终结？
Herz. 2018 Feb;43(1):20-25. doi: 10.1007/s00059-017-4649-z.
6
Is oral anticoagulation plus antiplatelet therapy superior to oral anticoagulation alone in patients with atrial fibrillation and stable coronary artery disease?
J Interv Card Electrophysiol. 2023 Aug;66(5):1031-1032. doi: 10.1007/s10840-022-01379-7. Epub 2022 Oct 15.
7
Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?非瓣膜性心房颤动患者行经皮冠状动脉介入治疗中的抗血栓治疗：在 PIONEER AF-PCI 和 RE-DUAL PCI 试验之后，我们是否应该改变我们的治疗实践？
Clin Res Cardiol. 2018 Jul;107(7):533-538. doi: 10.1007/s00392-018-1242-2. Epub 2018 Apr 20.
8
Concomitant Use of Antiplatelets and Anticoagulants in Patients with Coronary Heart Disease and Atrial Fibrillation: What Do Recent Clinical Trials Teach Us?冠心病合并心房颤动患者双联抗血小板与抗凝治疗：近期临床试验给我们带来哪些启示？
Curr Atheroscler Rep. 2018 Jan 19;20(1):4. doi: 10.1007/s11883-018-0703-4.
9
Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous coronary intervention.接受经皮冠状动脉介入治疗的非瓣膜性心房颤动患者预防长期主要不良心血管事件的抗栓策略。
Expert Opin Pharmacother. 2017 Jun;18(9):875-883. doi: 10.1080/14656566.2017.1329822. Epub 2017 May 22.
10
Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience.双联（抗凝加单抗血小板）与三联（抗凝加双抗血小板）抗栓治疗 - “真实世界”经验。
Prog Cardiovasc Dis. 2018 Jan-Feb;60(4-5):531-536. doi: 10.1016/j.pcad.2018.01.010. Epub 2018 Jan 31.